{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T07:20:34Z","timestamp":1789802434619,"version":"4.0.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.amjms.2026.09.003","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T06:38:19Z","timestamp":1789799899000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The development of Clostridioides difficile Infection is associated with the severity of liver disease and worsens survival in acutely decompensated cirrhosis"],"prefix":"10.1016","author":[{"given":"Ainhoa","family":"Fern\u00e1ndez-Yunquera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Carri\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Di\u00e9guez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Villaseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Conthe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maricela","family":"Valerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aranzaz\u00fa","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"D\u00edaz-Fontenla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Ba\u00f1ares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Rinc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.amjms.2026.09.003_bib0001","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2020.06.013","article-title":"The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology","volume":"73","author":"Trebicka","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.amjms.2026.09.003_bib0002","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/jhep.2002.30082","article-title":"Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis","volume":"35","author":"Fernandez","year":"2002","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.amjms.2026.09.003_bib0003","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/hep.25947","article-title":"Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American Consortium for the Study of End-Stage Liver Disease (NACSELD) experience","volume":"56","author":"Bajaj","year":"2012","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.amjms.2026.09.003_bib0004","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1053\/j.gastro.2010.06.019","article-title":"Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis","volume":"139","author":"Arvaniti","year":"2010","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.amjms.2026.09.003_bib0005","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/lt.24139","article-title":"High risk of delisting or death in liver transplant candidates following infections: results from the North American Consortium for the Study of End-Stage Liver Disease","volume":"21","author":"Reddy","year":"2015","journal-title":"Liver Transpl"},{"issue":"13","key":"10.1016\/j.amjms.2026.09.003_bib0006","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1306801","article-title":"Multistate point-prevalence survey of health care-associated infections","volume":"370","author":"Magill","year":"2014","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.amjms.2026.09.003_bib0007","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1056\/NEJMra0707500","article-title":"Clostridium difficile-more difficult than ever","volume":"359","author":"Kelly","year":"2008","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.amjms.2026.09.003_bib0008","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1128\/CMR.00082-09","article-title":"The changing epidemiology of Clostridium difficile infections","volume":"23","author":"Freeman","year":"2010","journal-title":"Clin Microbiol Rev"},{"issue":"9491","key":"10.1016\/j.amjms.2026.09.003_bib0009","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0140-6736(05)67420-X","article-title":"Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe","volume":"366","author":"Warny","year":"2005","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.amjms.2026.09.003_bib0010","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMra1403772","article-title":"Clostridium difficile infection","volume":"372","author":"Leffler","year":"2015","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.amjms.2026.09.003_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110790","article-title":"Acid suppression therapy does not predispose to Clostridium difficile infection: the case of the potential bias","volume":"9","author":"Novack","year":"2014","journal-title":"PLoS One"},{"issue":"35","key":"10.1016\/j.amjms.2026.09.003_bib0012","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.3748\/wjg.v23.i35.6500","article-title":"Proton pump inhibitors therapy and risk of Clostridium difficile infection: systematic review and meta-analysis","volume":"23","author":"Trifan","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.amjms.2026.09.003_bib0013","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.cmi.2014.11.001","article-title":"Predicting the risk of Clostridium difficile infection following an outpatient visit: development and external validation of a pragmatic, prognostic risk score","volume":"21","author":"Kuntz","year":"2015","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"10.1016\/j.amjms.2026.09.003_bib0014","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1007\/s10096-015-2501-z","article-title":"Clostridium difficile infection in patients with liver disease: a review","volume":"34","author":"Trifan","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"10.1016\/j.amjms.2026.09.003_bib0015","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1017\/S0950268818001036","article-title":"Outcomes associated with Clostridium difficile infection in patients with chronic liver disease","volume":"146","author":"Dotson","year":"2018","journal-title":"Epidemiol Infect"},{"issue":"1","key":"10.1016\/j.amjms.2026.09.003_bib0016","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ajg.2009.615","article-title":"Clostridium difficile is associated with poor outcomes in patients with cirrhosis: a national and tertiary center perspective","volume":"105","author":"Bajaj","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.amjms.2026.09.003_bib0017","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","author":"Angeli","year":"2018","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.amjms.2026.09.003_bib0018","first-page":"303","article-title":"Clostridium difficile infection and liver disease","volume":"19","author":"Musa","year":"2010","journal-title":"J Gastrointestin Liver Dis"},{"issue":"6","key":"10.1016\/j.amjms.2026.09.003_bib0019","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jhep.2014.01.024","article-title":"Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013","volume":"60","author":"Jalan","year":"2014","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.amjms.2026.09.003_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12418","article-title":"European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection","volume":"20","author":"Debast","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.amjms.2026.09.003_bib0021","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII Faculty. Baveno VII-renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.amjms.2026.09.003_bib0022","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cix1085","article-title":"Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"9759","key":"10.1016\/j.amjms.2026.09.003_bib0023","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0140-6736(10)61266-4","article-title":"Clostridium difficile infection in Europe: a hospital-based survey","volume":"377","author":"Bauer","year":"2011","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.amjms.2026.09.003_bib0024","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.14309\/ajg.0000000000001278","article-title":"ACG Clinical Guidelines: prevention, diagnosis, and treatment of Clostridioides difficile infections","volume":"116","author":"Kelly","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.amjms.2026.09.003_bib0025","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s10096-017-2991-y","article-title":"An outbreak of Clostridium difficile PCR ribotype 027 in Spain: risk factors for recurrence and a novel treatment strategy","volume":"36","author":"Bouza","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.amjms.2026.09.003_bib0026","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1053\/j.gastro.2009.02.073","article-title":"Clostridium difficile infection caused by the epidemic BI\/NAP1\/027 strain","volume":"136","author":"O\u2019Connor","year":"2009","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.amjms.2026.09.003_bib0027","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1086\/596703","article-title":"Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program study","volume":"48","author":"Gravel","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.amjms.2026.09.003_bib0028","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3201\/eid1205.051350","article-title":"Clostridium difficile ribotype 027, toxinotype III, the Netherlands","volume":"12","author":"Kuijper","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"10.1016\/j.amjms.2026.09.003_bib0029","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1111\/ajt.12798","article-title":"Clostridium difficile infection in liver transplant recipients: a retrospective study of rates, risk factors and outcomes","volume":"14","author":"Mittal","year":"2014","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.amjms.2026.09.003_bib0030","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/liv.14077","article-title":"The rise of Clostridioides difficile infections and fall of associated mortality in hospitalized advanced cirrhotics","volume":"39","author":"Rosenblatt","year":"2019","journal-title":"Liver Int"},{"issue":"8","key":"10.1016\/j.amjms.2026.09.003_bib0031","doi-asserted-by":"crossref","first-page":"932","DOI":"10.4254\/wjh.v13.i8.926","article-title":"Clostridioides difficile infection in liver cirrhosis patients: a population-based study in United States","volume":"13","author":"Sahra","year":"2021","journal-title":"World J Hepatol"},{"issue":"1","key":"10.1016\/j.amjms.2026.09.003_bib0032","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/apt.12797","article-title":"Prevalence and in-hospital mortality trends of infections among patients with cirrhosis: a nationwide study of hospitalized patients in the United States","volume":"40","author":"Singal","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.amjms.2026.09.003_bib0033","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4254\/wjh.v15.i2.208","article-title":"Clostridioides difficile infection in patients with nonalcoholic fatty liver disease: current status","volume":"15","author":"Kiseleva","year":"2023","journal-title":"World J Hepatol"},{"issue":"10","key":"10.1016\/j.amjms.2026.09.003_bib0034","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/j.1432-2277.2007.00530.x","article-title":"Early and late onset Clostridium difficile-associated colitis following liver transplantation","volume":"20","author":"Albright","year":"2007","journal-title":"Transpl Int"},{"key":"10.1016\/j.amjms.2026.09.003_bib0035","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12879-023-08096-0","article-title":"The burden of CDI in the United States: a multifactorial challenge","volume":"23","author":"Feuerstadt","year":"2023","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1016\/j.amjms.2026.09.003_bib0036","doi-asserted-by":"crossref","first-page":"423","DOI":"10.15403\/jgld.2014.1121.244.csd","article-title":"Clostridium difficile infection in hospitalized cirrhotic patients with hepatic encephalopathy","volume":"24","author":"Stoica","year":"2015","journal-title":"J Gastrointestin Liver Dis"},{"issue":"7","key":"10.1016\/j.amjms.2026.09.003_bib0037","article-title":"Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosis","volume":"7","author":"Zacharias","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.amjms.2026.09.003_bib0038","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/cid\/cix918","article-title":"Breakthrough Clostridium difficile infection in cirrhotic patients receiving rifaximin","volume":"66","author":"Reigadas","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.amjms.2026.09.003_bib0039","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/j.1478-3231.2012.02830.x","article-title":"Prognostic indicators of survival in patients with compensated and decompensated cirrhosis","volume":"32","author":"Zipprich","year":"2012","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.amjms.2026.09.003_bib0040","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s10620-020-06162-0","article-title":"Trends in hospitalizations for Clostridioides difficile infection in end-stage liver disease, 2005-2014","volume":"66","author":"Kim","year":"2021","journal-title":"Dig Dis Sci"},{"issue":"8","key":"10.1016\/j.amjms.2026.09.003_bib0041","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/MCG.0000000000000868","article-title":"Predictors of mortality in cirrhosis inpatients with Clostridium difficile infection","volume":"52","author":"Smith","year":"2018","journal-title":"J Clin Gastroenterol"},{"issue":"8","key":"10.1016\/j.amjms.2026.09.003_bib0042","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1097\/MCG.0000000000001090","article-title":"Early readmission predicts increased mortality in cirrhosis patients after Clostridium difficile infection","volume":"53","author":"Kruger","year":"2019","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.amjms.2026.09.003_bib0043","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.cmi.2021.09.038","article-title":"European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults","volume":"27","author":"van Prehn","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"10.1016\/j.amjms.2026.09.003_bib0044","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1007\/s10620-015-3707-8","article-title":"Hospitalized patients with cirrhosis should be screened for Clostridium difficile colitis","volume":"60","author":"Saab","year":"2015","journal-title":"Dig Dis Sci"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962926003630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962926003630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T06:38:25Z","timestamp":1789799905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962926003630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":44,"alternative-id":["S0002962926003630"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2026.09.003","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The development of Clostridioides difficile Infection is associated with the severity of liver disease and worsens survival in acutely decompensated cirrhosis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2026.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of Southern Society for Clinical Investigation.","name":"copyright","label":"Copyright"}]}}